Streetbeat News

Revenues

OC

Owens-Corning (NYSE:OC) has received mixed analyst ratings over the past three months, with an average 12-month price target of $161.0, reflecting a 21.05% increase from the previous target. The company, a manufacturer of glass fiber, faces challenges in revenue growth and ROE but excels in net margin and ROA. Analysts from Barclays, Goldman Sachs, and JP Morgan have updated their ratings and price targets, indicating varying expectations for the company's performance.

Portfolio Pulse from Benzinga Insights

February 12, 2024 | 1:00 pm

U

Unity Software (NYSE:U) has received mixed analyst ratings over the past three months, with a shift towards a more bearish outlook in the last 30 days. The average 12-month price target for Unity Software has increased to $31.0 from $23.0, indicating a 34.78% rise. Analysts from Macquarie, Goldman Sachs, Piper Sandler, and HSBC have provided updates, with price targets ranging from $20.00 to $37.00. Unity Software, known for its real-time 3D content creation platform, has shown a significant revenue growth rate of 68.55% as of September 30, 2023, but faces challenges in net margin, ROE, and ROA.

Portfolio Pulse from Benzinga Insights

February 12, 2024 | 1:00 pm

TTD

Trade Desk (NASDAQ:TTD) has received varied analyst ratings over the past three months, with a shift from bullish to a more stable outlook. Despite no changes in the last 30 days, the average 12-month price target for TTD has increased to $82.8, up from $79. This reflects a positive sentiment based on Trade Desk's solid revenue growth, market capitalization, and advertising platform performance. However, concerns about net margin, ROE, and ROA below industry benchmarks suggest areas for improvement.

Portfolio Pulse from Benzinga Insights

February 12, 2024 | 1:00 pm

SENS

Ascensia Diabetes Care and Senseonics announced that Medicare has expanded access to the Eversense E3 CGM System for basal-only patients, following the implementation of Local Coverage Determinations by the first three Medicare contractors. This expansion could significantly increase the user base of the Eversense E3 CGM System, potentially boosting Senseonics' market presence and financial performance.

Portfolio Pulse from Benzinga Newsdesk

February 12, 2024 | 12:20 pm

GNSS

Genasys Inc. (NASDAQ:GNSS) has been awarded a project by the Puerto Rico Electric Power Authority, funded by FEMA, to build an Emergency Warning System for 37 dams in Puerto Rico. The project, valued at $60M-$70M in revenue for Genasys, involves the use of the Genasys Protect platform for early flood threat detection and communication.

Portfolio Pulse from Benzinga Newsdesk

February 12, 2024 | 12:07 pm

BBGI

Beasley Broadcast Group (BBGI) reported Q4 earnings of $0.21 per share with sales of $65.70M, missing the consensus estimate of $66.05M by 0.53%. This represents an 8.78% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 12, 2024 | 12:03 pm

TRMB

Trimble has provided its financial guidance for FY24, expecting revenue between $3.57B and $3.67B, below the estimated $3.84B. Adjusted EPS is forecasted at $2.60-$2.80, around the $2.72 estimate. For Q1 2024, revenue is expected to be between $905M-$935M, below the $977.07M estimate, with adjusted EPS of $0.57-$0.62, under the $0.67 estimate. Both forecasts assume the closure of a joint venture with AGCO in Q2 2024.

Portfolio Pulse from Benzinga Newsdesk

February 12, 2024 | 12:02 pm

INDA

India's Consumer Price Index (CPI) for January reported a year-over-year increase of 5.10%, slightly above the estimated 5.09% and below the prior 5.69%.

Portfolio Pulse from Benzinga Newsdesk

February 12, 2024 | 12:02 pm

TEVA

Over the last three months, 8 analysts have provided diverse opinions on Teva Pharmaceutical Industries (NYSE:TEVA), with recent ratings ranging from bullish to bearish. The average 12-month price target for TEVA has been raised to $14.25, marking a 24.67% increase from the previous average of $11.43. Analysts from firms including Piper Sandler, Goldman Sachs, Barclays, Jefferies, HSBC, and UBS have adjusted their ratings and price targets, reflecting a generally positive outlook on the company. Teva, a leading generic drug manufacturer, has shown a positive revenue trend with a growth rate of 15.77% as of December 31, 2023, and has outperformed in net margin and ROE, despite a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

February 12, 2024 | 12:01 pm

MHK

Mohawk Industries (NYSE:MHK) received mixed analyst ratings, with a shift towards more positive evaluations in the last quarter. The average 12-month price target for MHK has increased by 22.44% to $114.6. Analysts from Deutsche Bank, Wells Fargo, RBC Capital, Goldman Sachs, and Barclays have adjusted their ratings and price targets, reflecting changes in market dynamics and company performance. Despite a -5.56% decline in revenue growth for the last 3 months of 2023, MHK demonstrates strong profitability and financial health, with impressive net margin, ROE, and ROA, and a conservative debt management approach.

Portfolio Pulse from Benzinga Insights

February 12, 2024 | 12:00 pm